1 month Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Consensus Recommendation of “Moderate Buy” from BrokeragesMarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) has been given an average rating of “Moderate Buy” by the thirteen ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a h…
X